Eileen Kennedy - Koninklijke DSM Member of the Supervisory Board

Executive

Ms. Eileen Kennedy has served as Independent Member of the Supervisory Board of Royal DSM NV since May 11, 2012. She is the Company Chairman of the Sustainability Committee and Member of the Nomination Committee. She is Professor of Nutrition Friedman School of Nutrition Science and Policy at Tufts University in Boston . She also holds directorships at High LevelPanel of Experts on Food Security and Nutrition of the UN Committee on World Food Security. since 2012.
Age 71
Tenure 12 years
Phone31 45 578 8111
Webhttps://www.dsm.com

Koninklijke DSM Management Efficiency

The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 10 records

EXECUTIVE Age

Kyle RoseAvient Corp
N/A
John MideaAvient Corp
60
Amy EvinsAvient Corp
N/A
Michael BridgfordBridgford Foods
42
Christine ChangHf Foods Group
42
Kristen GajewskiAvient Corp
42
Steven RobertsonHanover Foods
67
Robert JamesAvient Corp
N/A
Chris ColeBridgford Foods
N/A
Kurt SchueringAvient Corp
60
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. Royal D operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people. Koninklijke DSM NV [RDSMY] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Koninklijke DSM NV Leadership Team

Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Routs, Chairman of the Supervisory Board
Eileen Kennedy, Member of the Supervisory Board
Ewald Kist, Deputy Chairman of the Supervisory Board
Frits Paasschen, Independent Member of the Supervisory Board
John Ramsay, Independent Member of the Supervisory Board
Stefan Doboczky, Member of the Managing Board
Paul Gilgen, Head Products
Lieke JongTops, Communications Mang
Stephan Tanda, Member of the Managing Board
Geraldine Matchett, CFO and Member of the Managing Board
Luca Rosetto, VP Products
Dimitri Vreeze, Member of the Managing Board
Dave Huizing, Vice President Investor Relations
Rob Atsma, Head Nederland
Pauline Mohr, Member of the Supervisory Board
Victoria Haynes, Member of the Supervisory Board
Jan Wolters, Head Chemicals
Bruno Mller, Head Products
Pradeep Pant, Member of the Supervisory Board
Manfred Eggersdorfer, VP Advocacy
Feike Sijbesma, Chairman of the Managing Board and CEO
Pierre Hochuli, Member of the Supervisory Board
Tom Swaan, Member of the Supervisory Board

Koninklijke Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke DSM in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke DSM's short interest history, or implied volatility extrapolated from Koninklijke DSM options trading.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Koninklijke OTC Stock

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Directory
Find actively traded commodities issued by global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance